| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcce400533289d53d3b87feb041e6b41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db46e4fffe431e52877f423b76ba8312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de5961f3c7c00eea0ff030250e71c8bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4764f3d399e24e02f806d5fc77ea02d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d08795cd1b7c65c675372ba9f79e00e4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-815
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-13 |
| filingDate |
2010-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3abbb2ed72c1d13c1dae79309a827cc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2feb2a3b74405383bccf3bae438673f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_090259eeab56960d8758b086d200beba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9dffa9104eedee5e54c6630124c162d |
| publicationDate |
2013-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8592564-B2 |
| titleOfInvention |
Immunoassays for lamotrigine |
| abstract |
Generally, the present invention relates to lamotrigine analogs that have substituents at the triazine 3-position and on the benzene 4-position and 5-position. The lamotrigine analogs can include immunogenic moieties that can be used to prepare anti-lamotrigine antibodies, or antigenic moieties that can be used in immunodiagnostic assays for lamotrigine. Also, the lamotrigine analog can include tracer moieties for detecting the presence or amount of the analog during an immunodiagnostic assay. Additionally, the lamotrigine analogs can be used in immunodiagnostic assays to compete with lamotrigine for binding with anti-lamotrigine antibodies. |
| priorityDate |
2004-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |